Carcinoid tumors are rare, indolent, neuroendocrine tumors that are most commonly found in the gastrointestinal tract and lungs. They occasionally develop in the head and neck, either as a primary tumor or, more commonly, as a metastasis. The most common sites of head and neck carcinoids are the larynx and middle ear. Only a few cases of carcinoid in the nasal cavity and paranasal sinuses have been reported. We describe a case of primary typical carcinoid of the frontal sinus in a 61-year-old man, and we review the clinical, imaging, surgical, and histochemical fi ndings in this case. The patient was treated with endoscopic resection. A subsequent workup for metastatic and occult primary disease was negative, confi rming that the frontal sinus was the primary source. At follow-up 12 months postoperatively, the patient remained without disease. To the best of our knowledge, this is the fi rst report of a primary typical carcinoid tumor originating in the frontal sinus.
Introduction
Tumors of the nasal cavity and paranasal sinuses account for only 3% of all carcinomas of the head and neck and less than 1% of all malignancies. 1 The most common site is the maxillary sinus (~60% of cases); other locations include the nasal cavity (~30%), ethmoid sinus (~10%), and frontal and sphenoid sinuses (~4%). 1 As is the case in other locations of the head and neck, the most common neoplasm in the paranasal sinuses is squamous cell carcinoma. Other neoplasms include adenocarcinoma, lymphoma, melanoma, neuroblastoma, and carcinoid tumors.
Carcinoid tumors are rare, slowly growing tumors that originate in the neural crest cells of the neuroendocrine system. They most frequently occur in the gastrointestinal tract (~67% of cases) and the tracheobronchial system (~25%), but they can arise in any location that contains endocrine cells, including the head and neck. 2, 3 The most common sites of carcinoid tumors in the head and neck, in descending order of frequency, are the larynx, middle ear, and paranasal sinuses.
Neuroendocrine tumors have been categorized according to several different systems. They can be classifi ed by grade (well-differentiated, moderately differentiated, or poorly differentiated), by World Health Organization type (typical, atypical, small cell, or neuroendocrine), 4 and by biochemical activity (typical or atypical) based on the production of vasoactive substances such as serotonin. 5 Because neuroendocrine tumors are often indolent, they may not become clinically signifi cant until mass effects, metastatic spread, or symptoms of carcinoid syndrome (e.g., fl ushing, bronchospasm, right-sided heart failure, and diarrhea) manifest. Once believed to be relatively benign, neuroendocrine tumors are now considered to be more malignant. 5 Moreover, their incidence appears to be increasing. 5 Carcinoid syndrome can occur after metastasis to the lungs or liver, where functional lesions can release vasoactive substances into the systemic circulation. 5 The liver and lung metabolize many of the neurosecretory substances, preventing systemic effects until metastasis develops. Carcinoid syndrome occurs in only 10% of all patients with carcinoid tumors; it is most often associated with midgut tumors. 5 We present what we believe is the fi rst reported case www.entjournal.com ■ E14
A of a primary typical carcinoid tumor of the frontal sinus. We describe the clinical, imaging, surgical, and histochemical fi ndings in this case, as well as the patient's management and outcome.
Case report
A 61-year-old man was referred to an ambulatory care clinic at a tertiary care academic medical center for evaluation of a long-standing history of right nasal congestion. He had previously been treated with antibiotics for presumed sinusitis, but his symptoms persisted. Physical examination and rigid nasal endoscopy revealed the presence of a solid mass in the right nasal cavity. No lymphadenopathy of the neck was present, and fi ndings on the remainder of the head and neck examination were unremarkable. Computed tomography (CT) and magnetic resonance imaging (MRI) of the sinuses detected a soft-tissue density in the anterior right nasal passage (fi gure 1). The lesion had originated in the right frontal sinus and extended along the nasal septum into the right anterior ethmoid sinus and the right maxillary sinus. The expansile mass had not caused any bony destruction or erosion into the anterior cranial fossa. The patient was taken to the operating room and administered general anesthesia for diagnostic biopsies of the right nasal cavity mass and for intraoperative histology of frozen sections. Intraoperatively, the mass was diagnosed as a vascular tumor. A complete endoscopic resection of the tumor with appropriate margins was performed. The operation included an endoscopic modifi ed Lothrop procedure. Permanent specimens were submitted for histopathologic and immunochemical examinations (fi gure 2). Analysis revealed densely cellular areas with moderately enlarged nuclei and fi ne granular chromatin. Mitotic fi gures were very rare, and no necrosis was identifi ed. Immunohistochemical staining was positive for synaptophysin and chromogranin and negative for pituitary hormones, CD31, CD34, smooth-muscle actin, and cytokeratins. These characteristics were unusual for a primary nasal cavity mass, and the tumor was fi nally classifi ed several weeks later as a typical carcinoid. After the fi nal diagnosis was established, further imaging of the neck, chest, and abdomen was performed. The radiographic studies demonstrated no other lesion, metastatic disease, or occult primary malignancy.
The patient tolerated the procedure well, and fi ndings on follow-up over a 14-month period were unremarkable. A subsequent metastatic workup, including serum studies, was negative, confi rming the diagnosis of a primary paranasal sinus carcinoid tumor. Because a 
Discussion
Carcinoids are often asymptomatic and found incidentally. When symptoms do occur, they are vague and nonspecifi c, which can lead to long delays in diagnosis. Indeed, the average interval between symptom onset and diagnosis is more than 9 years. 5 Carcinoids are diagnosed by microscopy and immunohistochemical studies with chromogranin, synaptophysin, neuronspecifi c enolase, and cytokeratins. Typical carcinoids are well-differentiated lesions and are distinguished from moderately differentiated atypical carcinoid tumors by the absence of mitoses, pleomorphism, and necrosis. 6 Typical carcinoids are also less aggressive and are managed differently, so making an accurate diagnosis is critical. Some neuroendocrine carcinomas of the sinonasal tract are high-grade carcinomas (sinonasal neuroendocrine carcinoma), and some are undifferentiated carcinomas that retain only lower-order neuroendocrine expression (sinonasal undifferentiated carcinoma). While the tumor in our patient exhibited a less "organoid" or cohesive cell-nest growth pattern than does the typical pulmonary-type carcinoma, the paucity of mitoses, lack of necrosis, and the smooth, uniform nuclear euchromatin pattern differentiated this tumor histologically from the more common high-grade neuroendocrine carcinomas in this region and supported the diagnosis of a lower-grade neuroendocrine malignancy.
Serum and urine analyses are useful diagnostic studies. A 24-hour urine sample for levels of the serotonin metabolite 5-hydroxyindoleacetic acid can detect functional carcinoids. Serum levels of chromogranin A, a glycoprotein secreted with neuroendocrine tumor hormones, is 80% sensitive and 95% specifi c. 5 Imaging is also useful in diagnosis. A multimodality approach that includes CT and MRI is recommended. 5 Endoscopic ultrasonography, meta-iodobenzylguanidine scintigraphy, and positron-emission tomography may also be helpful in the diagnosis of neuroendocrine tumors. Recent reports suggest somatostatin-receptor scintigraphy with pentetreotide as the study of choice in the management of carcinoid tumor patients. 3 Worldwide, the annual incidence of carcinoid tumors is 1.9 per 100,000 persons, with 67% of these lesions occurring in the gastrointestinal tract and 25% occurring in the tracheobronchial system. 2, 3 Other locations include the liver, gallbladder, thymus, and head and neck. Neuroendocrine carcinomas of the paranasal sinuses are rare, as fewer than 25 cases have been in the literaturemost of them being metastatic lesions. 1 The treatment of typical carcinoid tumors of the paranasal sinuses has not been established, owing to its rare nature and a paucity of retrospective case studies. Treatment is based on the location of the primary tumor and guided by whether or not metastasis has occurred. Options include surgery, radiotherapy, and chemotherapy with somatostatin analogues such as octreotide. 5 Complete surgical excision has been the most successful intervention, 2 with radio-and chemotherapy being reserved for patients who are poor surgical candidates and for those who have metastatic disease. 5 The role of adjuvant therapy in addition to surgery has not been established. Radio-and chemotherapy are not believed to be necessary for nonmetastatic tumors that are confi ned to one area. Elective neck dissection is recommended only when cervical disease is clinically evident. 6 In our patient, the typical carcinoid of the frontal sinus was treated with complete endoscopic resection without additional treatment modalities, and the patient remained disease-free after surgery.
In conclusion, only a few cases of carcinoid tumors of the nasal cavity and paranasal sinuses have been reported. To the best of our knowledge, our patient represents the fi rst reported case of a primary typical carcinoid of the frontal sinus. Despite the rarity of this fi nding, the possibility of a carcinoid should be considered for any nasal cavity or sinus mass because a high clinical suspicion is necessary to diagnose this indolent disease with nonspecifi c symptoms. Early and accurate diagnosis can have a signifi cant impact on the outcome and prognosis of patients with a rare neuroendocrine tumor of the head and neck.
